NCT01843153View on ClinicalTrials.gov

Continuous Versus Intermittent Sciatic Block for Total Knee Arthroplasty

PHASE4CompletedINTERVENTIONAL
Enrollment

140

Participants

Timeline

Start Date

April 30, 2013

Primary Completion Date

October 31, 2014

Study Completion Date

December 31, 2014

Conditions
Total Knee ArthroplastyPain
Interventions
DRUG

Ropivacaine

Trial Locations (1)

D-51375

KKH Dormagen, Dormagen

All Listed Sponsors
lead

Kreiskrankenhaus Dormagen

OTHER

NCT01843153 - Continuous Versus Intermittent Sciatic Block for Total Knee Arthroplasty | Biotech Hunter | Biotech Hunter